Active Biotech AB (publ) (ACTI.ST)
ACTI.ST Stock Price Chart
Explore Active Biotech AB (publ) interactive price chart. Choose custom timeframes to analyze ACTI.ST price movements and trends.
ACTI.ST Company Profile
Discover essential business fundamentals and corporate details for Active Biotech AB (publ) (ACTI.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Dec 2003
Employees
6.00
Website
https://www.activebiotech.comCEO
Helen Tuvesson
Description
Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Biotech AB (publ) was incorporated in 1983 and is headquartered in Lund, Sweden.
ACTI.ST Financial Timeline
Browse a chronological timeline of Active Biotech AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 6 Nov 2025
Earnings released on 21 Aug 2025
Earnings released on 8 May 2025
EPS came in at -kr 0.01 .
Earnings released on 13 Feb 2025
EPS came in at -kr 0.02 .
Earnings released on 22 Oct 2024
EPS came in at -kr 0.01 .
Earnings released on 22 Aug 2024
EPS came in at -kr 0.03 .
Earnings released on 9 May 2024
EPS came in at -kr 0.03 .
Earnings released on 8 Feb 2024
EPS came in at -kr 0.04 .
Stock split effective on 15 Nov 2023
Shares were split 139 : 125 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2023
EPS came in at -kr 0.04 .
Earnings released on 24 Aug 2023
EPS came in at -kr 0.04 .
Earnings released on 26 Apr 2023
EPS came in at -kr 0.04 .
Earnings released on 9 Feb 2023
EPS came in at -kr 0.05 .
Earnings released on 3 Nov 2022
EPS came in at -kr 0.06 .
Stock split effective on 17 Aug 2022
Shares were split 25 : 24 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 4 Aug 2022
EPS came in at -kr 0.07 .
Earnings released on 21 Apr 2022
EPS came in at -kr 0.07 .
Earnings released on 10 Feb 2022
EPS came in at -kr 0.06 .
Earnings released on 4 Nov 2021
EPS came in at -kr 0.05 .
Earnings released on 5 Aug 2021
EPS came in at -kr 0.06 .
Earnings released on 22 Apr 2021
EPS came in at -kr 0.05 .
Earnings released on 11 Feb 2021
EPS came in at -kr 0.02 , while revenue for the quarter reached kr 6.23M .
Stock split effective on 30 Dec 2020
Shares were split 1191 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 5 Nov 2020
EPS came in at -kr 0.05 .
ACTI.ST Stock Performance
Access detailed ACTI.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.